Published in Eur J Immunol on October 01, 1996
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet (2007) 6.83
A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood (2005) 4.64
MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response. Blood (2008) 2.71
Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med (1998) 2.57
Natural killer cell education and tolerance. Cell (2010) 2.02
Current perspectives of natural killer cell education by MHC class I molecules. Nat Rev Immunol (2010) 1.83
Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. J Exp Med (2005) 1.76
KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation. Blood (2005) 1.74
Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells. Immunol Rev (2008) 1.74
Acquisition of Ly49 receptor expression by developing natural killer cells. J Exp Med (1998) 1.60
Enhanced NK-cell development and function in BCAP-deficient mice. Blood (2008) 1.53
Cutting edge: viral infection breaks NK cell tolerance to "missing self". J Immunol (2008) 1.46
Copy number variation of KIR genes influences HIV-1 control. PLoS Biol (2011) 1.44
Activating Receptor Signals Drive Receptor Diversity in Developing Natural Killer Cells. PLoS Biol (2016) 1.38
Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I transgene. J Exp Med (1997) 1.38
Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection. J Exp Med (1996) 1.18
Innate immune control of HIV. Cold Spring Harb Perspect Med (2012) 1.09
2B4 (CD244)-CD48 interactions provide a novel MHC class I-independent system for NK-cell self-tolerance in mice. Blood (2005) 1.05
Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells. Nat Immunol (2012) 1.05
Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in natural killer cell development. J Exp Med (1997) 0.96
Natural killer cell tolerance persists despite significant reduction of self MHC class I on normal target cells in mice. PLoS One (2010) 0.96
Expression of natural killer receptor alleles at different Ly49 loci occurs independently and is regulated by major histocompatibility complex class I molecules. J Exp Med (2001) 0.94
Probing natural killer cell education by Ly49 receptor expression analysis and computational modelling in single MHC class I mice. PLoS One (2009) 0.93
Deletion of PI3K-p85alpha gene impairs lineage commitment, terminal maturation, cytokine generation and cytotoxicity of NK cells. Genes Immun (2008) 0.91
Genetic control of natural killing and in vivo tumor elimination by the Chok locus. J Exp Med (1998) 0.90
Complex expression of natural killer receptor genes in single natural killer cells. Immunology (2002) 0.90
HLA-Cw7 zygosity affects the size of a subset of CD158b+ natural killer cells. J Clin Immunol (2002) 0.86
Natural killer cell inhibitory receptor expression in humans and mice: a closer look. Front Immunol (2013) 0.84
Contrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistance. J Immunol (2013) 0.82
Newtonian cell interactions shape natural killer cell education. Immunol Rev (2015) 0.81
The balancing act: inhibitory Ly49 regulate NKG2D-mediated NK cell functions. Semin Immunol (2006) 0.81
Modulation of Ly49A receptors on mature cells to changes in major histocompatibility complex class I molecules. Immunology (1998) 0.80
Receptor/ligand avidity determines the capacity of Ly49 inhibitory receptors to interfere with T-cell receptor-mediated activation. Immunology (2003) 0.78
Selection and adaptation of cells expressing major histocompatibility complex class I-specific receptors of the natural killer complex. J Exp Med (1997) 0.78
Prenatal Allospecific NK Cell Tolerance Hinges on Instructive Allorecognition through the Activating Receptor during Development. J Immunol (2015) 0.77
Listeria monocytogenes infection affects a subset of Ly49-expressing NK cells in the rat. PLoS One (2010) 0.75
Regulation of natural killer cell function: a role for the NK cell's own MHC class I molecules. Med Microbiol Immunol (2005) 0.75
Immunoreceptor tyrosine-based inhibitory motif-dependent functions of an MHC class I-specific NK cell receptor. Proc Natl Acad Sci U S A (2017) 0.75
Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature (1990) 8.57
Properties and applications of monoclonal antibodies directed against determinants of they Thy-1 locus. J Immunol (1979) 7.79
CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature (1992) 7.15
Developmental potential and dynamic behavior of hematopoietic stem cells. Cell (1986) 5.98
Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol (2000) 5.45
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature (2001) 4.93
Developmental regulation of T-cell receptor gene expression. Nature (1985) 4.53
B-cell-stimulatory factor 2 (beta 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells. Proc Natl Acad Sci U S A (1987) 3.33
Viral infections induce abundant numbers of senescent CD8 T cells. J Immunol (2001) 3.04
Diversity, rearrangement, and expression of murine T cell gamma genes. Cell (1986) 2.81
Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med (1998) 2.57
Global transcriptional response of Bacillus subtilis to heat shock. J Bacteriol (2001) 2.49
The MHC reactivity of the T cell repertoire prior to positive and negative selection. Cell (1997) 2.34
Positive selection determines T cell receptor V beta 14 gene usage by CD8+ T cells. J Exp Med (1989) 2.22
Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity (1999) 2.18
Fractionation of lymphocyte populations with monoclonal antibodies specific for LYT-2.2 and LYT-3.1. J Immunol (1980) 1.86
Class I dependence of the development of CD4+ CD8- NK1.1+ thymocytes. J Exp Med (1994) 1.84
The role of Ly49A and 5E6(Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts. Immunity (1996) 1.84
Expression and function of interleukin-2 receptors on immature thymocytes. Nature (1985) 1.82
Cytotoxic T lymphocytes produce immune interferon in response to antigen or mitogen. J Exp Med (1982) 1.76
NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells. J Immunol (2000) 1.72
Allelic exclusion of Ly49-family genes encoding class I MHC-specific receptors on NK cells. Nature (1995) 1.71
Immunology. Antigens for gamma/delta T cells. Nature (1989) 1.65
Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol Rev (1997) 1.60
Acquisition of Ly49 receptor expression by developing natural killer cells. J Exp Med (1998) 1.60
Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity (1995) 1.58
The basis for self-tolerance of natural killer cells in beta2-microglobulin- and TAP-1- mice. J Immunol (1997) 1.58
A differentiation factor required for the expression of cytotoxic T-cell function. Nature (1982) 1.56
T-cell receptor variable region gene usage in T-cell populations. Proc Natl Acad Sci U S A (1986) 1.56
Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hematopoietic stem cells. Proc Natl Acad Sci U S A (1990) 1.49
Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells. J Exp Med (1999) 1.45
Selection is not required to produce invariant T-cell receptor gamma-gene junctional sequences. Nature (1993) 1.45
Mechanisms for the mechanical plasticity of tracheal smooth muscle. Am J Physiol (1995) 1.39
Ordered rearrangement of variable region genes of the T cell receptor gamma locus correlates with transcription of the unrearranged genes. J Exp Med (1993) 1.36
Strategies for target cell recognition by natural killer cells. Immunol Rev (2001) 1.31
Identification of a T-cell-specific transcriptional enhancer located 3' of C gamma 1 in the murine T-cell receptor gamma locus. Proc Natl Acad Sci U S A (1991) 1.30
Characterization of a novel murine T cell-activating factor. J Immunol (1987) 1.29
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer. Br J Cancer (2004) 1.27
Memory CD8 T lymphocytes express inhibitory MHC-specific Ly49 receptors. Eur J Immunol (2000) 1.27
Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. Eur J Immunol (1997) 1.27
Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes. J Exp Med (2000) 1.23
NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules. Eur J Immunol (2000) 1.21
Expression and function of NK cell receptors in CD8+ T cells. Curr Opin Immunol (2001) 1.20
Class I-deficient hemopoietic cells and nonhemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts. J Immunol (1997) 1.19
Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection. J Exp Med (1996) 1.18
Evidence that gammadelta versus alphabeta T cell fate determination is initiated independently of T cell receptor signaling. J Exp Med (2001) 1.18
Mechanisms for the mechanical response of airway smooth muscle to length oscillation. J Appl Physiol (1985) (1997) 1.18
T-cell lineages, repertoire selection and tolerance induction. Immunol Rev (1988) 1.17
Selected contribution: plasticity of airway smooth muscle stiffness and extensibility: role of length-adaptive mechanisms. J Appl Physiol (1985) (2001) 1.17
CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin 4. J Exp Med (1993) 1.16
Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC. Immunity (2000) 1.15
Immunology. A sense of something missing. Nature (1992) 1.13
MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model. Eur J Immunol (2001) 1.12
2F1 antigen, the mouse homolog of the rat "mast cell function-associated antigen", is a lectin-like type II transmembrane receptor expressed by natural killer cells. Eur J Immunol (1998) 1.09
Predominant variable region gene usage by gamma/delta T cell receptor-bearing cells in the adult thymus. J Exp Med (1988) 1.09
The role of viral enhancer "core" motif-related sequences in regulating T cell receptor-gamma and -delta gene expression. J Immunol (1993) 1.08
Application of FTA sample collection and DNA purification system on the determination of CTG trinucleotide repeat size by PCR-based Southern blotting. J Clin Lab Anal (1999) 1.08
Expression of the V beta 5.1 gene by murine peripheral T cells is controlled by MHC genes and skewed to the CD8+ subset. J Immunol (1990) 1.07
Events that regulate differentiation of alpha beta TCR+ and gamma delta TCR+ T cells from a common precursor. Semin Immunol (1997) 1.06
Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor. J Immunol (1999) 1.05
The developmental fate of T cells is critically influenced by TCRgammadelta expression. Immunity (1998) 1.04
IL-6 and IL-1 synergize to stimulate IL-2 production and proliferation of peripheral T cells. J Immunol (1989) 1.03
Role of contractile protein activation in the length-dependent modulation of tracheal smooth muscle force. Am J Physiol (1996) 1.03
DNA repair signature is associated with anthracycline response in triple negative breast cancer patients. Breast Cancer Res Treat (2010) 1.02
Defective development of gamma/delta T cells in interleukin 7 receptor-deficient mice is due to impaired expression of T cell receptor gamma genes. J Exp Med (1999) 1.02
The immunobiology of gamma delta+ T cells. Semin Immunol (1990) 1.00
Developmentally programmed rearrangement of T cell receptor Vgamma genes is controlled by sequences immediately upstream of the Vgamma genes. Immunity (1998) 1.00
Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs. Sleep Res Online (2000) 1.00
Class I MHC molecules on hematopoietic cells can support intrathymic positive selection of T cell receptor transgenic T cells. Proc Natl Acad Sci U S A (1999) 0.97
Natural killer cells: stress out, turn on, tune in. Curr Biol (1999) 0.97
Major histocompatibility complex genes determine natural killer cell tolerance. Eur J Immunol (1996) 0.96
Ly49A transgenic mice provide evidence for a major histocompatibility complex-dependent education process in natural killer cell development. J Exp Med (1997) 0.96
The role of short homology repeats and TdT in generation of the invariant gamma delta antigen receptor repertoire in the fetal thymus. Immunity (1995) 0.96
Expression of the Ly49A gene in murine natural killer cell clones is predominantly but not exclusively mono-allelic. Eur J Immunol (1997) 0.96
Cumulative inhibition of NK cells and T cells resulting from engagement of multiple inhibitory Ly49 receptors. J Immunol (2001) 0.96
Neuronal degeneration in canine narcolepsy. J Neurosci (1999) 0.95
Rearrangement by inversion of a T-cell receptor delta variable region gene located 3' of the delta constant region gene. Proc Natl Acad Sci U S A (1989) 0.93
The role of c-Myb or a related factor in regulating the T cell receptor gamma gene enhancer. J Immunol (1995) 0.92
Accelerated clearance of polyethylene glycol-modified proteins by anti-polyethylene glycol IgM. Bioconjug Chem (1999) 0.92
Phosphorylation of dense-plaque proteins talin and paxillin during tracheal smooth muscle contraction. Am J Physiol (1995) 0.91
T cells produce TRF in response to Con A and factors in T cell hybridoma supernatants. J Immunol (1982) 0.91
Evidence that productive rearrangements of TCR gamma genes influence the commitment of progenitor cells to differentiate into alpha beta or gamma delta T cells. Eur J Immunol (1995) 0.91
Pediatric Hodgkin lymphoma: are we over-scanning our patients? Pediatr Hematol Oncol (2012) 0.90
Role of IL-6, IL-1, and CD28 signaling in responses of mouse CD4+ T cells to immobilized anti-TCR monoclonal antibody. J Immunol (1994) 0.90
Inhibitory effects of class I molecules on murine NK cells: speculations on function, specificity and self-tolerance. Semin Immunol (1995) 0.90
Role of Rho in Ca(2+)-insensitive contraction and paxillin tyrosine phosphorylation in smooth muscle. Am J Physiol Cell Physiol (2000) 0.90
Toward a quantitative analysis of the repertoire of class I MHC-specific inhibitory receptors on natural killer cells. Curr Top Microbiol Immunol (1998) 0.90
Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells. Eur J Immunol (1994) 0.89
Congenital multiple plaque-like glomangiomyoma in trunk--a case report. Kaohsiung J Med Sci (2001) 0.87
Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions. Respir Med (1998) 0.87
A novel element upstream of the Vgamma2 gene in the murine T cell receptor gamma locus cooperates with the 3' enhancer to act as a locus control region. J Exp Med (1999) 0.86
Effects of cobalt-60 exposure on health of Taiwan residents suggest new approach needed in radiation protection. Dose Response (2006) 0.86
An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer. Br J Cancer (2006) 0.85
Mechanisms of seizure suppression during rapid-eye-movement (REM) sleep in cats. Brain Res (1989) 0.85
Contraction history modulates isotonic shortening velocity in smooth muscle. Am J Physiol (1993) 0.85
Helper T cells for cytotoxic T lymphocytes need not be I region restricted. J Exp Med (1982) 0.84
A phase I feasibility and pharmacokinetic study of intrapleural paclitaxel in patients with malignant pleural effusions. Anticancer Drugs (1997) 0.84
Counterproductive transcriptional and translational regulation of elongation factor 1-alpha synthesis during early development in sea urchins. Dev Biol (1990) 0.84